NT-I7 for the Treatment of Recurrent Squamous Cell Carcinoma of Head and Neck Undergoing Surgery
Conditions: Recurrent Head and Neck Squamous Cell Carcinoma; Recurrent Hypopharyngeal Squamous Cell Carcinoma; Recurrent Laryngeal Squamous Cell Carcinoma; Recurrent Oral Cavity Squamous Cell Carcinoma; Recurrent Oropharyngeal Squamous Cell Carcinoma; Resectable Oropha ryngeal Squamous Cell Carcinoma Intervention: Biological: Efineptakin alfa Sponsors: Hyunseok Kang, MD; NeoImmuneTech Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials